Apostle, headquartered in Sunnyvale, Calif., hopes to file an IPO or establish other strong business collaborative routes in five years. Source: BioSpace

Generic drug giant spokesperson says resignation is effective immediately as Desai pursues other opportunities. Source: BioSpace

A look at six biopharma companies that may have major stock catalysts this year. Source: BioSpace

This is a market like the world has never seen. Source: BioSpace

With a trial on hold for more than six months, InVivo has been burning through cash and may not have enough financing to continue operations for much longer. Source: BioSpace

Based in Toronto, Ontario, Fibrocor Therapeutics was launched in January 2017. Source: BioSpace

The drug is the first available FDA-approved Peptide Receptor Radionuclide Therapy. Source: BioSpace

Novelion will slash an unknown number of jobs as it initiates "significant cost reduction plans." Source: BioSpace

Astra has Glaxo and its COPD treatment Trelegy Ellipta squarely in its sights. Source: BioSpace

During an international conference in Davos, Switzerland, President Donald Trump sat down with the leaders of several European life science companies to encourage more investment in the United States. Source:…